• Info
  • Insider Ownership

Insider Trading & Ownership of Sumita Ray

Location
Sunnyvale, CA
Signature
/s/ Rainer Erdtmann as Attorney-in-Fact for Sumita Ray
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Sumita Ray and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Sumita Ray has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Biomea Fusion, Inc. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Sumita Ray

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BMEA Biomea Fusion, Inc. Director 11 Jun 2025
CALA Calithera Biosciences, Inc. Svp, General Counsel & Chief Compliance Officer 25 Jan 2022
TIL Instil Bio, Inc. Chief Legal and Admin Officer 08 Jan 2023
VAXX Vaxxinity, Inc. Chief Legal, Comp & Admin Off 01 Nov 2023

Insider Transactions Reported by Sumita Ray:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.